New rapid tests for respiratory infections put to the test in africa

NCT ID NCT07651865

Recruiting now Diagnosis Sponsor: Karolinska Institutet Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study is testing new rapid tests (lateral flow and microfluidic devices) to detect respiratory infections in children and adults in Uganda, Ethiopia, and Senegal. Researchers want to see if these tests are accurate and easy to use in low-resource clinics. Participants with respiratory symptoms provide samples during one visit; no treatment is given.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to affordable, easy-to-use diagnostic tests for respiratory infections in low-resource areas, improving treatment decisions.
What could go wrong: This is an observational study, not a treatment trial. The tests may not be accurate enough or practical in real-world settings. Results are preliminary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOWER RESP TRACT INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

respiratory tract infectious disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOWER RESP TRACT INFECTION UPPER RESPIRATORY INFECTION

Contacts and locations

Locations

Armauer Hansen Research Institute (AHRI)
COMPLETED

Addis Ababa, Ethiopia
Epicentre Mbarara Research Centre
RECRUITING

Mbarara, Uganda
Institut Pasteur de Dakar
RECRUITING

Dakar, Senegal

More trials for these conditions

Other studies related to the condition(s) this trial covers.